Eutilex Co Ltd

263050

Company Profile

  • Business description

    Eutilex Co Ltd is a Korean that operates in the anti-tumor immunotherapy market. The company develops anti-tumor T cell therapy and antibody therapeutics based on its immunotherapy technology. Its pipeline products include T Cell Therapy (4-1BB CTL), CAR-T, and Antibody.

  • Contact

    Daeryung Technotown 17
    Suite 1401
    Gasan Digital 1-ro 25
    Geumcheon-gu
    Seoul08594
    KOR

    T: +82 234027310

    http://www.eutilex.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    141

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,374.0082.20-0.97%
CAC 407,727.9342.55-0.55%
DAX 4023,344.54257.891.12%
Dow JONES (US)41,218.8398.60-0.24%
FTSE 1008,596.3599.551.17%
HKSE22,504.68385.271.74%
NASDAQ17,844.24133.49-0.74%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,412.878.38-0.07%
S&P 5005,650.3836.29-0.64%
S&P/ASX 2008,157.8080.20-0.97%
SSE Composite Index3,279.037.62-0.23%

Market Movers